A Study to Evaluate the Safety and Efficacy of an Investigational Drug in HIV Infected Patients (0518-004)(COMPLETED)

NCT00100048 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

206

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV Infections
Acquired Immunodeficiency Syndrome

Interventions

DRUG: Comparator: MK0518 monotherapy
DRUG: Comparator: MK0518 combination therapy
DRUG: Comparator: efavirenz
DRUG: Comparator: tenofovir
DRUG: Comparator: lamivudine
DRUG: Placebo monotherapy

Sponsor

Merck Sharp & Dohme LLC